// June 08, 2023
Insights from India: Q&A with USP nitrosamines expert
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis
Many of the drug ingredients used in generic medicines around the world are produced in China, an
Validation and verification of analytical procedures are quality assurance activities with broad